Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Systematic Review

Accepted on 06 Jun 2025

Prognostic and Clinicopathological Value of DBC1 Expression in Human Cancers: A Systematic Review and Meta-Analysis

in Cancer Molecular Targets and Therapeutics

Haojia Wang
Xinhong Cheng
Xianzhuo Zhang
Yong Wang
Shuo Gao
Fanghui Ding
Xiaojing Song
Dandan Li
Haixu Ni
Yang Luo

Frontiers in Oncology

doi 10.3389/fonc.2025.1584622

Review

Published on 06 Jun 2025

Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence

in Cancer Molecular Targets and Therapeutics

Divya Vishambhar Kumbhakar
Lucky Thakkar
Chetana Akhand
Shehna Sharaf
Geeta K. Vemuganti

Frontiers in Oncology

doi 10.3389/fonc.2025.1499283

1,851 views

Correction

Accepted on 04 Jun 2025

correction: FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway

in Cancer Molecular Targets and Therapeutics

Yiming Li
Jianshen Liang
Xiude Ren
Jiahe Guo
Xisen Wang
Xuya Wang
Sheng Ping Yu
Tao Li
Xuejun Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1637363

182 views

Review

Accepted on 04 Jun 2025

Molecular Markers for the Efficacy of Neoadjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma

in Cancer Molecular Targets and Therapeutics

Jiabin Zhu
Yudong Ning

Frontiers in Oncology

doi 10.3389/fonc.2025.1586130

106 views

Review

Published on 04 Jun 2025

Research progress on NUSAP1 and its role in digestive system neoplasms

in Cancer Molecular Targets and Therapeutics

Shangui Fu
Yuting Zhuo
Tao Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1582361

523 views

Original Research

Published on 04 Jun 2025

Comprehensive pan-cancer analysis and experimental validation reveal FCHSD1 as a potential biomarker for diagnosis, immune infiltration, and prognosis

in Cancer Molecular Targets and Therapeutics

Ming Liu
Guixin Ding
Gonglin Tang
Shangjing Liu
Qiancheng Mao
Xidong Wang
Qingsong Zou
Jitao Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1547067

384 views

Original Research

Accepted on 03 Jun 2025

In-silico design and In-Vitro Validation of a Multi-Epitope Peptide Vaccine Targeting Triple-Negative Breast Cancer (TNBC)

in Cancer Molecular Targets and Therapeutics

Pengjun Zhou
Xing Shi
Jinquan Xia
Hong Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1611991

102 views

Original Research

Accepted on 02 Jun 2025

Risk factors for adverse reactions caused by abemaciclib in breast cancer therapy

in Cancer Molecular Targets and Therapeutics

Qie Guo
Xianghua Quan
CaiHong Sun
Bing Han
Chuanzhou Zhang
Huai Qin Cang
Xiaomin Xing

Frontiers in Oncology

doi 10.3389/fonc.2025.1529980

142 views

Systematic Review

Accepted on 02 Jun 2025

Efficacy and safety of Sacituzumab govitecan in solid tumors: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Yaping Zhang
Hongming Fang
Jian Chen
Xiaoyan Wang
Hui Wang
Xiaoli Chen
Jianfeng Hong

Frontiers in Oncology

doi 10.3389/fonc.2025.1624386

121 views

Perspective

Accepted on 30 May 2025

A spotlight on the MSc Cancer at UCL, 15 years on

in Cancer Molecular Targets and Therapeutics

Sarah Koushyar
John A Hartley

Frontiers in Oncology

doi 10.3389/fonc.2025.1610068

108 views

Original Research

Accepted on 30 May 2025

Network Pharmacology Integrated with Molecular Docking and Experimental Validation Elucidates the Therapeutic Potential of Forsythiae Fructus Extract Against Hepatitis B Virus-Related Hepatocellular Carcinoma

in Cancer Molecular Targets and Therapeutics

Fuqing Chen
Yifan Cai
Changzhou Chen
Jianyin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1571537

112 views

Original Research

Published on 30 May 2025

Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer

in Cancer Molecular Targets and Therapeutics

Mohammed Ali Alshehri
Hadil Alahdal
Akram Ahmed Aloqbi
Afnan Mohammed Shakoori
Ghadir Sindi
Rehab M. Bagadood
Nida Alsaffar
Mohammad Ahmad Alobaidy
Noof Abdulrahman Alrabiah
Md Khursheed

Frontiers in Oncology

doi 10.3389/fonc.2025.1598883

402 views

Original Research

Published on 30 May 2025

Metabolic profiling of glioblastoma and identification of G0S2 as a metabolic target

in Cancer Molecular Targets and Therapeutics

Jianlei Kang
Yujie Xu
Qitai Zhao
Ying Wang
Zhenyan He
Xin Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1572040

394 views

Original Research

Accepted on 29 May 2025

Design and Immunogenic Evaluation of Multi-Epitope Vaccines for Colorectal Cancer: Insights from Molecular Dynamics and In-Vitro Studies

in Cancer Molecular Targets and Therapeutics

Peiwei Sun
Luolin Wang
Zhong Liu
Zhenglei Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1592072

163 views

Mini Review

Published on 29 May 2025

Advancing targeted therapy for colorectal cancer: harnessing ligand-directed enzyme prodrug therapy for highly specific interventions

in Cancer Molecular Targets and Therapeutics

Hend Al-Jaber
Kabir H. Biswas
Layla Al-Mansoori

Frontiers in Oncology

doi 10.3389/fonc.2025.1570712

419 views

Correction

Published on 29 May 2025

Corrigendum: MiR-21 and let-7 cooperation in the regulation of lung cancer

in Cancer Molecular Targets and Therapeutics

Jinquan Bai
Zhenzhou Shi
Shuting Wang
Hong Pan
Tong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1602462

162 views